A phase 4 trial in Brazil finds 1-month and 3-month treatment regimens are safe and effective options for preventing active tuberculosis.

The H9N2 cases include a 2-year-old boy from Hunan province who got sick on December 29, and a 73-year-old woman from ...

A scourge for at least the past 6,000 years, tuberculosis (TB) is estimated by the World Health Organization (WHO) to be a latent infection in one ...

In a federally funded clinical trial led by Johns Hopkins Medicine, people with tuberculosis infections (but not HIV) in two ...

A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage of patients successfully ...

A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...

Drug-resistant tuberculosis remains one of the most persistent infectious disease threats, driven in large part by ...

Details concerning the Isoniazid medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA. Amlodipine besylate; benazepril hydrochloride capsule: Aurobindo Pharma USA and Novartis ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

Treatment of latent Mycobacterium tuberculosis infection with isonazid can cause hepatotoxicity, but the risk of isoniazid-associated hepatotoxicity among persons coinfected with hepatitis C virus ...